Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
27.89
+0.22 (0.80%)
Feb 10, 2026, 10:34 AM EST - Market open
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $19.96 billion as of February 10, 2026. Its market cap has increased by 145.49% in one year.
Market Cap
19.96B
Enterprise Value
15.38B
1-Year Change
145.49%
Ranking
Category
Stock Price
$27.89
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $19.96B, an increase of 3,642.37%. That is a compound annual growth rate of 101.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 19.80B | 31.22% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insmed | 31.89B |
| BioNTech SE | 27.69B |
| Royalty Pharma | 25.43B |
| Incyte | 21.41B |
| Genmab | 18.95B |
| Revolution Medicines | 18.70B |
| Moderna | 16.39B |
| BridgeBio Pharma | 13.93B |